![tyme technologies inc tyme technologies inc](https://www.annualreports.com/HostedData/_ara_prvw/68305.jpg)
Statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat,Ĭlick here for more on how to use these ratings. TYME is an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs) that are intended to be effective across a broad range of solid tumors and hematologic cancers, while also maintaining patients’ quality of life through relatively low toxicity profiles.
![tyme technologies inc tyme technologies inc](https://drpgazette.com/wp-content/uploads/2021/06/TYME-Chart-June-11-730x430.jpg)
(Nasdaq: TYME) (the Company or TYME), an emerging biotechnology company developing cancer metabolism-based therapies. Companies with ratings are not formally covered by a Morningstar analyst, but are Meitav Dash Investments Ltd closes position in RFLGF / Tyme Technologies Inc. BEDMINSTER, N.J., (GLOBE NEWSWIRE) - TYME Technologies, Inc. Peer companies that do receive analyst-driven ratings. Morningstar Quantitative ratings for equities (denoted on this page by ) are generated using an algorithm that compares companies that are not under analyst coverage to
#Tyme technologies inc code#
Davidson is guided by Morningstar, Inc.'s Code of EthicsĪnd Personal Securities Trading Policy in carrying out his responsibilities. Is responsible for overseeing the methodology that supports the quantitative fair value.
![tyme technologies inc tyme technologies inc](https://images.fintel.io/us-tyme-fails-to-deliver.png)
Lee Davidson, Head of Quantitative Research for Morningstar, Inc., Fundamental company data provided by Morningstar, updated daily.There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate isĪttributed to however, Mr. Stock quotes provided by InterActive Data. The gurus listed in this website are not affiliated with, LLC. United Technologies Corporation, by change of name from United Aircraft Corpora1,025,091.
![tyme technologies inc tyme technologies inc](https://images.fintel.io/us-tyme-put-call-ratio.png)
The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. Past performance is a poor indicator of future performance. In no event shall be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on, or relating to the use of, or inability to use, or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. The Registered Agent on file for this company is Corporation Service Company and is located at 2711 Centerville Rd Suite 400, Wilmington, DE 19808. The companys File Number is listed as 5069024. These treatments are designed to work across a wide range of diagnoses, solid. Gurus may be added or dropped from the GuruFocus site at any time. is a Delaware Corporation filed On November 21, 2011. TYME Technologies is a new biotechnology company that develops cancer metabolism-based therapies or CMBTs. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Under no circumstances does any information posted on represent a recommendation to buy or sell a security. BEDMINSTER, N.J., Ma(GLOBE NEWSWIRE) - TYME Technologies, Inc. This investment adviser does not provide advice to individual investors. Announces Exploration of Strategic Options. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. Learn more about Tyme Technologies Incs (TYME) stock grades for Growth, Momentum and Quality and determine whether this Biotechnology & Medical Research. is not operated by a broker or a dealer.